相对粪便丰度预测产ESBL肠杆菌相关呼吸机相关性肺炎
这项单中心回顾性研究于2019年10月至2023年4月在大学医院内科ICU开展,纳入478例ESBL-E携带者,其中231例(48%)需机械通气,83例(17%)共发生131次确诊VAP,62次(47%)为ESBL-E相关VAP。粪便ESBL-E相对丰度(RAC)与ESBL-E相关VAP无关联(p=0.39),多项敏感性分析结果一致;多变量模型中非大肠埃希菌ESBL定植与ESBL-E相关VAP独立相关(aOR 1.213 [95%CI 1.005-1.463],p=0.045)。作者认为需进一步研究以改善ESBL-E携带者疑似VAP的抗菌药物管理。
要点
- 在478例ESBL-E携带者中,RAC与ESBL-E相关VAP无关联(p=0.39),不能据此预测ESBL-E相关VAP。
- 近期高质量筛查亚组(筛查距VAP≤7天且直肠拭子菌量>10^4 CFU/mL)中RAC仍无关联(p=0.21)。
- 仅首次VAP发作(p=0.41)、仅大肠埃希菌(p=0.08)、其他ESBL-E菌株(p=0.29)亚组中RAC均无关联。
- 革兰阴性菌相关VAP(p=0.26)与肠杆菌目相关VAP(p=0.34)亚组中RAC亦无关联。
- 多变量模型中非大肠埃希菌ESBL定植与ESBL-E相关VAP独立相关(aOR 1.213 [95%CI 1.005-1.463],p=0.045)。
适用人群与场景
- 2019年10月至2023年4月大学医院内科ICU收治的ESBL-E直肠携带者,共478例,其中231例(48%)需机械通气。
- 分析对象为ESBL-E携带者中确诊VAP的患者,共83例、131次VAP发作。
诊断标准与关键阈值
- ESBL-E直肠携带相对丰度(RAC)计算为ESBL-E菌落数与需氧耐氧细菌总数的比值。
- 近期高质量筛查定义为筛查距VAP≤7天且直肠拭子细菌载量>10^4 CFU/mL。
研究设计与关键结果
- 单中心回顾性研究,2019年10月至2023年4月内科ICU,478例ESBL-E携带者中231例(48%)需机械通气,83例(17%)发生131次确诊VAP,其中62次(47%)为ESBL-E相关VAP。
- 末次直肠筛查至VAP发生的中位间隔为4 [3-7]天。
- 整个队列中RAC与ESBL-E相关VAP无关联(p=0.39)。
- 近期高质量筛查亚组(间隔≤7天且直肠拭子菌量>10^4 CFU/mL)中RAC与ESBL-E相关VAP无关联(p=0.21)。
- 仅首次VAP发作亚组(p=0.41)、仅大肠埃希菌亚组(p=0.08)、其他ESBL-E菌株亚组(p=0.29)中RAC均无关联。
- 革兰阴性菌相关VAP亚组(p=0.26)与肠杆菌目相关VAP亚组(p=0.34)中RAC均无关联。
- 多变量模型中,非大肠埃希菌ESBL定植与ESBL-E相关VAP独立相关(aOR 1.213 [95%CI 1.005-1.463],p=0.045)。
证据类型、等级与局限
- 单中心回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,需进一步研究探索改善ESBL-E携带者疑似VAP抗菌药物管理的有效策略。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Antimicrobial stewardship (AMS) for ventilator-associated pneumonia (VAP) in carriers of extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E) presents significant challenges. The abundance of ESBL-E rectal carriage has emerged as a potentially valuable tool for predicting ESBL-E-related VAP.
METHODS: This single-center, retrospective study was conducted between October 2019 and April 2023 in the medical ICU of a university hospital. The relative abundance of ESBL-E rectal carriage (RAC) was calculated as the ratio of ESBL-E counts to the total number of aerotolerant bacteria. The aim was to evaluate the predictive value of RAC for diagnosing ESBL-E-related VAP in patients with confirmed VAP who were ESBL-E carriers.
RESULTS: During the study period, 478 patients with ESBL-E carriage were admitted to the ICU, of whom 231 (48%) required mechanical ventilation. Eighty-three patients (17%) developed a total of 131 confirmed VAP episodes, of which 62 episodes (47%) were ESBL-E-related VAP. The median interval between the last rectal screening and VAP occurrence was 4 [3-7] days. RAC was not associated with ESBL-E-related VAP in the entire cohort (p = 0.39). Similar findings were observed in several sensitivity analyses, including the following subsets: recent and high-quality screening (interval between screening and VAP ≤ 7 days and bacterial load on rectal swab > 104 CFU/mL, p = 0.21); first VAP episodes only (p = 0.41); cases involving Escherichia coli exclusively (p = 0.08) or other ESBL-E strains (p = 0.29); and VAP associated with Gram-negative bacteria (p = 0.26) or Enterobacterales (p = 0.34). However, in a multivariable model, rectal colonization with non-Escherichia coli ESBL strains was independently associated with ESBL-E-related VAP (adjusted odds ratio [aOR] 1.213 [95% CI 1.005-1.463], p = 0.045).
CONCLUSION: RAC was not associated with confirmed VAP in ESBL-E carriers. Further studies are needed to explore effective strategies for improving AMS in ESBL-E carriers with suspected VAP.
参考来源
- Bay P, Woerther PL, Fihman V, et al. Relative faecal abundance to predict extended-spectrum β-lactamase-producing Enterobacterales related ventilator‑associated pneumonia. Ann Intensive Care. 2025. PMID: 40113731. doi:10.1186/s13613-025-01456-w
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。